University of California San Francisco
Give to UCSF
Poor Night’s Sleep Can Trigger Atrial Fibrillation the Next Day
A bad night of sleep was associated with a 15% greater risk of having an atrial fibrillation (A-Fib) episode the following day, along with conditions like blood clots, heart failure, stroke and other heart-related problems.
Eczema and Asthma Share a Link. Can it Lead to New Treatments?
A collaboration is between two biomedical researchers bridges the laboratory and clinic to advance the science of itch, allergy and asthma.
Do Combination Therapies Hold Hope for Prostate Cancer Patients?
A phase 1 trial shows promise in treating metastatic prostate cancer with a single priming dose of radioligand therapy and immunotherapy.
Breast Cancer Riddle: Best Ways to Screen and Treat
Laura Esserman discusses breast cancer risk factors, progress in the field and the importance of tailoring treatment for women with low-risk cancer while also identifying women at high risk of invasive cancer.
Why Progress in Alzheimer’s Disease Treatment Has Taken 30 Years
UCSF's Adam Boxer, MD, PhD, and Harvard neurologist Reisa Sperling, MD, review the history of clinical trials over the past 30 years in Alzheimer’s research with what was learned and how new biomarkers and clinical trial approaches are being used to find more effective treatments in a more efficient way than in the past.
New Care Model Delivers Hepatitis C Treatment to Most Vulnerable
UCSF researchers developed a new neighborhood-based model of care that brings medicine to people immediately after being diagnosed with hepatitis C.
Homeless People Are 16 Times More Likely to Die Suddenly
A UCSF-led found that people who are experiencing homelessness have a 16-fold higher rate of sudden death from heart attacks, as well as other causes.
Does Suspending Kids from School Harm Their Grades and Health?
Being suspended from school or sent to the office is tied to a big drop in grade point average (GPA), especially for Black and Latinx children.
Breakthrough Drug Helps Children with New-Onset Type 1 Diabetes
A study found that children who were recently diagnosed with type 1 diabetes need less supplemental insulin to keep their blood sugar in a healthy range if they use the immunotherapy drug teplizumab.
